Top Story Morning Read: Valeant slashes sales staff for women’s libido pill Addyi By Meghana Keshavan
Top Story From Denver’s new digital health center to a doctor’s take on Addyi approval: 5 must-read stories from MedCity News this week By Nicole Oran
Top Story, Pharma Some doctors are speaking out about concerns with the FDA’s approval of Addyi By Nicole Oran
Pharma Top sex doc on FDA approval of Addyi, women’s libido pill: ‘A nuclear bomb has exploded in women’s sexual health’ By Meghana Keshavan
Top Story Morning Read: Senate hears of drug price gouging; Martin Shkreli is a big Wu-Tang fan By Neil Versel
Top Story Morning Read: Valeant wants to buy Sprout in $1B deal, Allscripts and CoverMyMeds collaborate By Nicole Oran
